Behavioral Health

Somatic symptom disorder in primary care: A collaborative approach

Author and Disclosure Information

 

References

3. Maintain professionalism and good clinical practice. Consider SSD a medical matter and address it accordingly: explore concerns fully, provide evidence-based responses, communicate empathy, and employ objective management strategies.14

4. Do not overlook the value of the relationship. A recent systematic review concluded that the relationship between the patient and care provider was central to the success of the interventions for symptom reduction.15

A controversial approach. Pharmacotherapy for SSD is controversial. While several trials of antidepressants and St. John’s wort have been positive and some authors have stated that all classes of antidepressants are effective for SSD, others maintain that questions regarding dosing, treatment duration, and sustainability of improvement have not been sufficiently addressed in research.16,17

Coordination of care issues

Primary care continues to be the de facto mental health system, and specialty services may be unavailable or declined by patients.18 CBT delivered in person or online is empirically supported as a treatment approach to medically unexplained symptoms and SSD.17,19-22

A recent meta-analysis of randomized controlled trials published by Jing and colleagues23 reported that CBT was effective for SSD symptom reduction, and that treatment gains were maintained 3 to 12 months post treatment. However, concerns about the practical implementation of CBT in primary care were raised because CBT was not shown to be effective in improving social functioning or reducing the number of medical visits. Symptom improvement was maximized with longer durations of treatment (> 10 sessions) and greater session lengths (> 50 minutes). Additionally, Abbass and colleagues24 brought up several methodologic (sampling and analysis) concerns related to Jing et al’s work.

Continue to: Overally, CBT's effect sizes...

Pages

Recommended Reading

Epidural may lower odds of severe maternal birth complications
MDedge Family Medicine
Practice guidelines highlights from past year
MDedge Family Medicine
Mindfulness intervention curbs opioid misuse, chronic pain
MDedge Family Medicine
Dyspareunia: Keys to biopsychosocial evaluation and treatment planning
MDedge Family Medicine
FDA, DEA pushed to make gabapentin a controlled substance to stop ‘widespread misuse’
MDedge Family Medicine
Addiction expert says CBD may help people cut cannabis use
MDedge Family Medicine
Orphenadrine recalled due to possible nitrosamine impurity
MDedge Family Medicine
A saliva test for diagnosing endometriosis?
MDedge Family Medicine
Medical cannabis may cut opioid use for back pain, OA
MDedge Family Medicine
Denosumab boosts bone strength in glucocorticoid users
MDedge Family Medicine